Respiratory

Back to articles

Beta-blocker use is associated with fewer COPD hospitalizations and deaths

KEY POINT

Data from a large Danish population–based study showed that treatment with beta-blockers, regardless of their selectivity on bronchial tone, was associated with a reduced risk of chronic obstructive pulmonary disease (COPD) hospitalizations and death from COPD compared with use of other antihypertensive agents, according to a study published in EClinicalMedicine.

SOURCES

Nielsen AO, et al. β-blocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.3 million individuals. EClinicalMedicine. 2019;[Epub ahead of print].

Ambrosio G, et al. Who's afraid of the big bad wolf? Safety of beta-blockers in COPD. EClinicalMedicine. 2019;[Epub ahead of print].

Agostini P, et al. Lung function with carvedilol and bisoprolol in chronic heart failure: Is β selectivity relevant? Eur J Heart Failure. 2007;9(8):827–33.